LISTEN NOW: Get the Skinny on GLP-1s — Pharmacy Friends podcast

In this episode, industry experts discuss clinical evidence, drug information and appropriate patient selection for GLP1 use.

January 9, 2024

A hot topic in the health care industry is GLP-1s and chronic weight management.

In this first of a two-part episode of the Pharmacy Friends podcast, “The Skinny on GLP-1s: Part 1,” our experts discuss clinical evidence, drug information and appropriate patient selection for GLP-1 use.

Hosting this episode is Maryam Tabatabai, vice president for clinical information at Prime/MRx. She is joined by Olivia Pane, a clinical pharmacist at Prime/MRx, who also is a certified diabetes care and education specialist who focuses on the management and treatment of diabetes, weight gain and other chronic conditions. Maryam also speaks with Carole Kerzic, a drug information, and pipeline clinical pharmacist at Prime/MRx, who has extensive expertise following emerging therapeutics and investigational drugs from pipeline to post-FDA approval.

“I’m looking forward to more real-world experience with these drugs, and pharmacy organizations will play a pivotal role in staying on top of emerging data and providing education and evidence-based information to not only prescribers but also patients,” Pane said.

These experts discuss the role of lifestyle modification, upcoming drug pipeline decision and even tackle how celebrities and social media influencers have impacted the availability of these medicines.

“I’m looking forward to more real-world experience with these drugs, and pharmacy organizations will play a pivotal role in staying on top of emerging data and providing education and evidence-based information to not only prescribers but also patients,” Olivia Pane, PharmD, CDCES.

Pharmacy Friends is a podcast dedicated to bringing industry experts to the same table to talk about what is happening in pharmacy today, what is coming, and most importantly, what it means to you. You can listen to the full episode “The Skinny on GLP-1s: Part 1,” on https://www.primetherapeutics.com/pharmacy-friends/.

Related news

Stories

May 15, 2024

Prime/MRx experts share clinical insights for migraine treatment

Drs. Tracey Garcia and Amy Pappas, board-certified neurologists, reviewed migraine risk factors and treatments in a recent webinar moderated by Dr. Marci Chodroff, vice president of medical affairs

Stories

May 14, 2024

Prime/MRx real-world GLP-1 persistence and adherence data published in Journal of Managed Care & Specialty Pharmacy

Among the key findings from the study — among 4,066 members, Prime/MRx found 1 in 3 stayed on their GLP-1 and 27% took their medication as intended

Stories

May 14, 2024

Prime/MRx releases its first corporate social responsibility report

New report, an evolution of previous DEI reports, aims to demonstrate transparency and accountability for company’s corporate social responsibility journey